ERIS LIFESCIENCESERIS LIFESCIENCESERIS LIFESCIENCES

ERIS LIFESCIENCES

No trades
See on Supercharts
Market capitalization
‪118.38 B‬INR
‪3.82 B‬INR
‪16.85 B‬INR
‪33.48 M‬
Beta (1Y)
0.34

About ERIS LIFESCIENCES

CEO
Amit Indubhushan Bakshi
Headquarters
Ahmedabad
Website
Employees (FY)
‪3.46 K‬
Founded
2007
ISIN
INE406M01024
FIGI
BBG00GX73BH6
Eris Lifesciences Ltd. engages in the provision of pharmaceutical products. Its brands include Eritel, Glimsave, Renerve, Tendia, Olmin, Rabonik, Tayo, Cyblex, Remylin, Zomelis, Crevast, Atorsave, Ginkocer and Metital. The firm markets and distributes pharmaceutical drugs, such as tablets, syrups and injections. The company was founded by Amit Indubhushan Bakshi on January 25, 2007 and is headquartered in Ahmedabad, India.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ERIS is 875.10 INR — it has increased by 0.55% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange ERIS LIFESCIENCES stocks are traded under the ticker ERIS.
ERIS LIFESCIENCES is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
ERIS stock is 2.91% volatile and has beta coefficient of 0.34. Check out the list of the most volatile stocks — is ERIS LIFESCIENCES there?
One year price forecast for ERIS LIFESCIENCES has a max estimate of 1230.00 INR and a min estimate of 930.00 INR.
ERIS earnings for the last quarter are 9.10 INR per share, whereas the estimation was 9.03 INR resulting in a 0.74% surprise. The estimated earnings for the next quarter are 7.70 INR per share. See more details about ERIS LIFESCIENCES earnings.
ERIS LIFESCIENCES revenue for the last quarter amounts to ‪5.05 B‬ INR despite the estimated figure of ‪5.05 B‬ INR. In the next quarter revenue is expected to reach ‪4.93 B‬ INR.
Yes, you can track ERIS LIFESCIENCES financials in yearly and quarterly reports right on TradingView.
ERIS stock has risen by 3.44% compared to the previous week, the month change is a 2.77% rise, over the last year ERIS LIFESCIENCES has showed a 41.15% increase.
ERIS net income for the last quarter is ‪1.03 B‬ INR, while the quarter before that showed ‪1.23 B‬ INR of net income which accounts for −16.77% change. Track more ERIS LIFESCIENCES financial stats to get the full picture.
Today ERIS LIFESCIENCES has the market capitalization of ‪118.38 B‬, it has decreased by 0.04% over the last week.
ERIS LIFESCIENCES dividend yield was 1.28% in 2022, and payout ratio reached 26.15%. The year before the numbers were 0.87% and 20.11% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, ERIS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ERIS LIFESCIENCES stock right from TradingView charts — choose your broker and connect to your account.
ERIS reached its all-time high on Nov 9, 2023 with the price of 971.90 INR, and its all-time low was 321.00 INR and was reached on Mar 13, 2020.
See other stocks reaching their highest and lowest prices.
As of Apr 20, 2024, the company has ‪3.46 K‬ employees. See our rating of the largest employees — is ERIS LIFESCIENCES on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ERIS LIFESCIENCES technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ERIS LIFESCIENCES stock shows the buy signal. See more of ERIS LIFESCIENCES technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on ERIS LIFESCIENCES future price: according to them, ERIS price has a max estimate of 1230.00 INR and a min estimate of 930.00 INR. Read a more detailed ERIS LIFESCIENCES forecast: see what analysts think of ERIS LIFESCIENCES and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ERIS LIFESCIENCES EBITDA is ‪6.45 B‬ INR, and current EBITDA margin is 32.43%. See more stats in ERIS LIFESCIENCES financial statements.